Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Overview and Testing Methodologies
Description: Whitney Dodge, LCGC, Genetic Counselor explains the clinical signs and symptoms of FSHD and discusses the differences between Southern blot and molecular combing testing methodologies. After the presentation Whitney will be joined by expert Dr. Fatih Boyer, Science Director at Quest Diagnostics in San Juan Capistrano, to answer your most challenging questions.
At the end of this webinar, participants will be able to:
• Describe the clinical and molecular background of FSHD
• Explain the differences between Southern blot and molecular combing when diagnosing FSHD
• Cite advantages and limitations of each methodology